Stryker Corp. plans to sell its U.S. spinal implant business to a New York-based family office Viscogliosi Brothers LLC.

Barclays analyst Matt Miksic maintained a Buy rating on Stryker (SYK – Research Report) today and set a price target of $443.00. The company’s ...

Shares of Stryker Corp. SYK slipped 1.18% to $391.40 Friday, on what proved to be an all-around dismal trading session for ...

We recently published a list of 12 Best Automation Stocks To Buy According to Hedge Funds. In this article, we are going to ...

Learn more about whether Edwards Lifesciences Corporation or Stryker Corporation is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/19.CwRXVpI-.js ...

Medical technology company Stryker (NYSE:SYK) reported revenue ahead of Wall Street’s expectations in Q4 CY2024, with sales ...

What Happened: Pierce, Group President at Stryker, made a strategic move by exercising stock options for 9,455 shares of SYK as detailed in a Form 4 filing on Thursday with the U.S. Securities and ...

The rapid advancements in medical technology have been a major driver of growth for the Global Medical Equipment market Industry. US, NY, UNITED STATES, January 31, 2025 /EINPresswire / -- Medical ...

Notably, Stryker was named the most admired medtech company in the world. Another major orthopedic and spine device manufacturer, Medtronic, also earned a spot. 1. Stryker Corp.

Stryker (NYSE:SYK) reported operating results for the fourth quarter and full year of 2024: Fourth Quarter Results Reported net sales increased 10.7% ...

Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 21%. Looking ahead, revenue ...